Health

OTC medicines

Common over-the-counter pain, allergy, cold, and stomach remedies.

Why it matters · Households may see product pullbacks, substitutions, or temporary gaps in familiar retail medicines.

10

Inputs

24

Companies

8

Facilities

9

Source countries

How it's made

The process

  1. 01

    API synthesis

    Chemical synthesis of the active pharmaceutical ingredient at specialized plants: acetylation of para-aminophenol → acetaminophen; Friedel-Crafts acylation of isobutylbenzene → ibuprofen; acetylation of salicylic acid → aspirin. Performed overwhelmingly at Chinese and Indian API plants.

  2. 02

    Raw material testing and milling

    Incoming API and excipients tested for purity, potency, and particle size distribution per USP/EP monographs; milled to target particle size for uniform content and dissolution.

  3. 03

    Blending and granulation

    API blended with excipients (binders, fillers, disintegrants, lubricants). Wet or dry granulation creates uniform granules for consistent dosing across high-speed tablet presses.

  4. 04

    Compression or encapsulation

    Granules compressed into tablets on rotary tablet presses (up to billions of units/year per line), or filled into hard gelatin or HPMC capsule shells at encapsulation machines.

  5. 05

    Film coating

    Tablets receive HPMC-based film coating for taste masking, moisture barrier, and brand identification. Enteric coatings (e.g., Eudragit L) protect acid-sensitive APIs such as omeprazole and enteric aspirin.

  6. 06

    Packaging

    Tablets blistered (PVC/aluminum foil — dominant in EU) or bottled (HDPE — dominant in US). Secondary packaging adds cartons and inserts. Tamper-evident sealing applies to all US OTC products.

  7. 07

    Quality release testing and distribution

    Final batch release: dissolution, potency assay, microbiological testing. QA release sign-off; warehouse at ambient or controlled conditions; distribution to retail (pharmacy, mass market, grocery).

Where it comes from

Country dependencies

Weighted share of upstream inputs sourced from each country.

CountryWeighted shareInputs supplied to otc medicines
CNChina46%Acetaminophen (APAP) API · Aspirin (acetylsalicylic acid) API · Pharmaceutical blister packaging (PVC/aluminum) +4
CHSwitzerland30%Pharmaceutical capsule shells (gelatin / HPMC)
JPJapan26%Pharmaceutical capsule shells (gelatin / HPMC) · HPMC (hydroxypropyl methylcellulose) excipient
AUAustralia/Global22%Pharmaceutical blister packaging (PVC/aluminum)
INIndia20%Acetaminophen (APAP) API · Aspirin (acetylsalicylic acid) API · Pharmaceutical blister packaging (PVC/aluminum) +3
USUnited States12%Acetaminophen (APAP) API · HPMC (hydroxypropyl methylcellulose) excipient · Ibuprofen API
EUEuropean Unionno map12%Acetaminophen (APAP) API · Para-aminophenol (PAP) — APAP precursor
DEGermany9%Pharmaceutical blister packaging (PVC/aluminum) · Ibuprofen API
FRFrance9%Aspirin (acetylsalicylic acid) API

Who makes it

Supplier companies

24 companies in this supply chain, sorted by market share.

World's largest aspirin API producer since the 1980s; 10,000+ tonnes/year aspirin capacity; exports ~5,000 tonnes/year to Pfizer, Bayer, Sanofi, GSK, Abbott, and Novartis. Also produces APAP and analgesics. Listed on Shanghai Stock Exchange.

Supplies these inputs

Aspirin (acetylsalicylic acid) API

Replaceability

Substitutability 35% · 18 mo to replace

Business segments

  • Aspirin API — World Largest (45% Global Share)60% rev
  • Acetaminophen (APAP) API25% rev
  • Other Analgesics and Pharmaceutical Products15% rev

Shin-Etsu Chemical Co., Ltd. (Chiyoda-ku, Tokyo; TSE: 4063; ~¥2.1T revenue; ~$14B) is the world's largest PVC resin producer and one of its top two or three silicone producers globally, with approximately 15-20% global silicone market share. Shin-Etsu's silicones division produces KF-96 series dimethicone fluids (5 to 100,000 cSt viscosities) that are widely used in personal care formulations across Asia and globally — KF-96 is one of the most recognized cosmetic-grade dimethicone references in personal care ingredient databases. Primary silicone manufacturing is at Naoetsu, Niigata Prefecture (Japan Sea coast) and Gunma Prefecture plants. Shin-Etsu Chemical's enormous scale in both PVC and silicones makes it unique: the company produces chloromethane (methyl chloride) — the key Müller-Rochow process reagent — from its chlor-alkali operations, giving it vertical integration from chlorine production through dimethicone. Shin-Etsu also produces EUV photoresists, making it a supplier to both haircare formulators and TSMC's 3nm fab within the same corporate entity.

Supplies these inputs

HPMC (hydroxypropyl methylcellulose) excipient

Replaceability

Substitutability 40% · 18 mo to replace

Business segments

  • PVC & Chlor-Alkali36% rev
  • Silicones27% rev
  • Semiconductor & Electronics Materials25% rev
  • Functional Materials12% rev

World's largest single ibuprofen API manufacturer; claims 35% global market share; 12,000 tonnes/year capacity; the only company globally backward-integrated into isobutylbenzene (IBB), the key ibuprofen precursor. Received China NMPA approval April 2025 to export to China.

Supplies these inputs

Ibuprofen API

Replaceability

Substitutability 30% · 12 mo to replace

Business segments

  • Ibuprofen API — World Largest (35% Global Share)55% rev
  • Acetic Acid & Ethyl Acetate (Industrial)35% rev
  • Other APIs (Expanding)10% rev

Lonza Group AG (Visp, Switzerland; SIX: LONN; ~CHF 6.7B revenue) is the world's largest pharmaceutical and biotech CDMO (Contract Development and Manufacturing Organization). Primary business is biologic drug manufacturing (mammalian cell culture, microbial fermentation) for pharma clients. Manufactured Moderna COVID-19 mRNA. Sold Specialty Ingredients (biocides: benzalkonium chloride, quats) to Arxada in 2021. Capsules and health ingredients division (HPMC and gelatin capsules) is the world's largest hard capsule manufacturer.

Supplies these inputs

Pharmaceutical capsule shells (gelatin / HPMC)

Replaceability

Substitutability 25% · 24 mo to replace

Business segments

  • Bioscience CDMO (Primary Business)70% rev
  • Capsules and Health Ingredients25% rev
  • Biocides (Divested to Arxada 2021)5% rev
Dow Inc. (DOW)
HQ US28% share

Dow Inc. (Midland, Michigan; NYSE: DOW; ~$45B revenue) is a major global EPDM producer through its Performance Elastomers division, producing NORDEL EPDM. NORDEL is manufactured primarily at Dow's Freeport, Texas complex (one of the largest integrated chemical sites in North America) and at European facilities. NORDEL EPDM is used in automotive weatherstripping, roofing, wire insulation, and plumbing seals. Dow is estimated to hold ~15-18% of global EPDM capacity. The NORDEL brand has been a benchmark EPDM product since the 1960s (originally DuPont, transferred to Dow in 2019 DuPont-Dow merger split). Dow's integrated Freeport site gives it ethylene and propylene feedstock advantages for EPDM production cost.

Supplies these inputs

HPMC (hydroxypropyl methylcellulose) excipient

Replaceability

Substitutability 40% · 18 mo to replace

Business segments

  • Packaging & Specialty Plastics (Polyethylene)55% rev
  • Industrial Intermediates & Infrastructure30% rev
  • Performance Materials & Coatings15% rev
Novelis Inc.
HQ US25% share

American aluminum rolling company (HQ Atlanta GA; wholly owned by Hindalco Industries, Birla Group India; ~$18B revenue); world's largest producer of rolled aluminum products including pharmaceutical-grade aluminum foil used as blister pack lidding. Novelis' pharmaceutical foil division produces ultra-thin aluminum foil (20-45 µm) with pharmaceutical-grade cleanliness and pin-hole free specifications for blister lidding. Novelis is simultaneously the largest recycler of used aluminum beverage cans in North America (Coors Light, Bud Light cans) — the same company that provides the aluminum for beer cans also provides the pharmaceutical-grade aluminum foil lid on European blister packs. Novelis was spun off from Alcan (Canadian aluminum company) and acquired by Hindalco (India's Birla Group aluminum company) in 2007 for $6B — making an Indian industrial conglomerate the owner of the world's largest aluminum rolling company and a key pharmaceutical packaging material supplier.

Supplies these inputs

Pharmaceutical blister packaging (PVC/aluminum)

Replaceability

Substitutability 55% · 9 mo to replace

Business segments

  • Beverage Can Stock (World #1)40% rev
  • Automotive Aluminum25% rev
  • Pharmaceutical + Specialty Foil20% rev
  • Architectural + Specialty15% rev

Dutch specialty gelatin company (HQ Ghent Belgium / Arnhem Netherlands; subsidiary of Darling Ingredients, NYSE: DAR, HQ Irving TX); world's largest pharmaceutical gelatin producer, supplying the porcine and bovine gelatin used in hard-shell pharmaceutical capsules (including those made by Lonza Capsugel, ACG, and Qualicaps). Rousselot was founded in 1891 in Paris as a gelatin extractor from abattoir byproducts. The same collagen protein extracted from pig and cow hides/bones that becomes Rousselot pharmaceutical-grade gelatin also becomes food gelatin (Jello, gummy bears, marshmallows) and cosmetic collagen (face creams). The pharmaceutical capsule shell enclosing an APAP or ibuprofen tablet is made from the same material as a gummy bear — both from Rousselot's porcine or bovine hide hydrolysis. Darling Ingredients (Irving TX; formerly Darling International) processes animal byproducts globally — its Rousselot division captures the gelatin value from the same carcasses that its other divisions process for grease and protein meal.

Supplies these inputs

Pharmaceutical capsule shells (gelatin / HPMC)

Replaceability

Substitutability 30% · 24 mo to replace

Business segments

  • Pharmaceutical Gelatin35% rev
  • Food Gelatin30% rev
  • Nutraceutical Collagen (Peptan)25% rev
  • Technical & Industrial Gelatin10% rev

Global packaging company (NYSE: AMCR, HQ Zürich/Melbourne; ~$14B revenue); Amcor Flexibles Healthcare division produces multilayer pharmaceutical films including polyolefin coextruded films for IV bags and medical pouches. Amcor acquired Bemis Company in 2019 (Bemis was a major medical-grade flexible film producer). Amcor operates in 40+ countries with 400+ manufacturing sites — making it one of the world's most geographically diversified flexible packaging companies. Amcor's healthcare films must meet FDA 21 CFR 177.1520 (polyolefins for food/drug contact) and USP <661> plastics standards. The same Amcor that packages Cadbury chocolate bars and Arnott's biscuits in Australia also makes the sterile pharmaceutical packaging films for IV solutions.

Supplies these inputs

Pharmaceutical blister packaging (PVC/aluminum)

Replaceability

Substitutability 50% · 12 mo to replace

Business segments

  • Pharmaceutical Films (IV Bags & Pouches)40% rev
  • Food Flexible Packaging
  • Berry Global Healthcare (Post-Merger)15% rev
  • Rigid Pharmaceutical Packaging10% rev

World's largest single-site APAP (acetaminophen) API manufacturer; ~40,000–50,000 tonnes/year capacity; produces ~35% of Chinese APAP output; FDA DMF filed 2011. Also produces para-aminophenol (PAP) as an upstream integrated producer.

Supplies these inputs

Acetaminophen (APAP) API · Para-aminophenol (PAP) — APAP precursor

Replaceability

Substitutability 20% · 18 mo to replace

Business segments

  • Acetaminophen (APAP) API — World Largest Single Site65% rev
  • Para-Aminophenol (PAP) — Upstream Integration30% rev
  • Other APIs (Secondary)5% rev

Indian pharmaceutical packaging and machinery conglomerate (HQ Mumbai; private family-owned; the Rannvijay family; ~₹8,000 crore revenue); world's 2nd-largest capsule shell manufacturer (ACG Capsules division), alongside manufacturing pharmaceutical blister packaging films, pharmaceutical tablet coating systems, and capsule filling machines. ACG Capsules (Rajkot, Gujarat manufacturing) produces both gelatin and HPMC hard-shell capsules for Indian domestic market and export to EU/US regulated markets. ACG's integration across capsules, packaging films, and capsule filling equipment makes it uniquely positioned to serve the Indian generic pharmaceutical industry (India is the world's largest generic drug producer) with an end-to-end supply chain. ACG's capsule division serves customers including Sun Pharma, Cipla, Dr. Reddy's, and international companies. India's ACG is the primary non-Japanese non-Western alternative to Lonza Capsugel for pharma-grade hard-shell capsules.

Supplies these inputs

Pharmaceutical capsule shells (gelatin / HPMC)

Replaceability

Substitutability 30% · 24 mo to replace

Business segments

  • Capsule Shells (ACG Capsules)45% rev
  • Pharmaceutical Packaging Films (ACG Pampac)30% rev
  • Pharmaceutical Machinery (ACG Machinery)20% rev
  • Lab & Inspection (ACG Inspection)5% rev

Claims to be the world's largest integrated APAP producer; ~52,000–53,000 tonnes/year capacity; backward-integrated into para-aminophenol production; exports to 65+ countries. Key player in Indian API export growth.

Supplies these inputs

Acetaminophen (APAP) API

Replaceability

Substitutability 30% · 12 mo to replace

Business segments

  • Acetaminophen (APAP) API — World Largest Claims60% rev
  • Caffeine API25% rev
  • Other APIs & Intermediates15% rev

Chinese pharmaceutical and chemical company (SZSE: 002216, HQ Hengshui, Hebei; ~RMB 5B revenue); major producer of acetaminophen (paracetamol) API and its key precursor para-aminophenol (PAP). Hebei Jiheng is one of China's largest single-facility APAP producers and a major PAP manufacturer — controlling the full supply chain from aniline (derived from benzene/toluene/xylene petrochemicals) through PAP to APAP. Hebei province's chemical industry cluster (Hengshui, Shijiazhuang) includes multiple facilities producing the aniline, nitrobenzene, and para-aminophenol intermediates that feed APAP synthesis globally. Hebei Jiheng's PAP production capability makes it a critical upstream supplier not just for its own APAP but for Indian APAP producers (Farmson, Granules) who depend on Chinese PAP when domestic Indian PAP capacity is insufficient.

Supplies these inputs

Acetaminophen (APAP) API · Para-aminophenol (PAP) — APAP precursor

Replaceability

Substitutability 35% · 18 mo to replace

Business segments

  • Acetaminophen (APAP) API55% rev
  • Para-Aminophenol (PAP) Intermediates30% rev
  • Chemical Intermediates & Other15% rev

German specialty films company (HQ Montabaur, Rhineland-Palatinate; private equity owned — Triton Partners; ~€3B revenue); world's leading producer of pharmaceutical-grade PVC and PVdC films for blister packaging (Klöckner Pentaplast's pharma films brand 'kp'). Klöckner Pentaplast's pharmaceutical films are used in virtually all European and most global pharma blister packaging — from OTC pain relievers to prescription antibiotics and biologics. kp also produces food packaging films (deli trays, cheese packaging) and industrial films from the same manufacturing platform. Klöckner Pentaplast went through a debt restructuring in 2020 as private equity leverage proved unsustainable in the COVID year — a packaging company that makes the PVC holding most European pharmaceutical blister packs faced its own financial distress simultaneously with COVID-19 healthcare demand surge.

Supplies these inputs

Pharmaceutical blister packaging (PVC/aluminum)

Replaceability

Substitutability 55% · 9 mo to replace

Business segments

  • Pharma Films (kp Pharma)50% rev
  • Food & Specialty Packaging35% rev
  • Industrial & Technical Films15% rev

American specialty materials company (NYSE: ASH, HQ Wilmington DE; ~$2.5B revenue); produces pharmaceutical-grade HPMC under the Klucel HF brand (hydroxypropyl cellulose) and specialty cellulosic polymers for pharmaceutical tablet binders, extended-release matrices, and film coatings. Ashland traces to Ashland Oil Company (Kentucky; founded 1924 by J. Fred Miles) which progressively transformed from petroleum refiner to specialty chemicals — selling its petroleum assets in 2005 and transforming into a pharmaceutical and personal care excipient company. Ashland's pharmaceutical excipients serve virtually all major pharmaceutical manufacturers; its HPMC and HPC grades are in the majority of solid dose pharmaceutical formulations in the US.

Supplies these inputs

HPMC (hydroxypropyl methylcellulose) excipient

Replaceability

Substitutability 45% · 12 mo to replace

Business segments

  • Pharmaceuticals & Nutrition55% rev
  • Personal Care25% rev
  • Specialty Additives20% rev

Austrian flexible packaging company (HQ Vienna; private equity owned — Advent International 66%; Constantia Industries 34%; ~€1.8B revenue); one of Europe's largest flexible packaging producers including pharmaceutical blister packaging (PVC films, aluminum lidding foils, cold-form Alu-Alu blister materials). Constantia Flexibles' Pharma division serves European pharmaceutical manufacturers with regulatory-compliant PVC/PE blister films and pharmaceutical-grade aluminum foil. Constantia Flexibles also produces food packaging (coffee pods, butter wrappers, dairy) from the same packaging film manufacturing platform. The same Constantia Flexibles that packages coffee pods and butter also packages the ibuprofen tablets in European pharmacy shelves.

Supplies these inputs

Pharmaceutical blister packaging (PVC/aluminum)

Replaceability

Substitutability 55% · 9 mo to replace

Business segments

  • Pharma Packaging45% rev
  • Food Packaging45% rev
  • Labels & Decoration10% rev

Chinese specialty pharmaceutical chemical company (HQ Jingmen, Hubei; listed on Shanghai Stock Exchange); one of China's largest ibuprofen API producers, producing both ibuprofen and related NSAIDs (naproxen, ketoprofen) for domestic and export markets. Hubei Biocause's ibuprofen production contributes to China's dominant position in global ibuprofen API supply — which accounts for 90-95% of US/EU ibuprofen imports by volume. China's ibuprofen cost advantage stems from integrated petrochemical-pharmaceutical supply chains (isobutylbenzene, the key ibuprofen raw material, is a petroleum derivative produced cheaply in Chinese integrated chemical complexes).

Supplies these inputs

Ibuprofen API

Replaceability

Substitutability 30% · 24 mo to replace

Business segments

  • Ibuprofen API65% rev
  • Other NSAID APIs25% rev
  • Pharmaceutical Intermediates10% rev

Major Indian APAP and ibuprofen API and finished dosage form manufacturer; ~12% global APAP market share; 5 dedicated API plants; expanded capacity Q3 2024. Supplies global branded and generic OTC companies.

Supplies these inputs

Acetaminophen (APAP) API

Replaceability

Substitutability 35% · 12 mo to replace

Business segments

  • APAP + Ibuprofen APIs (Core OTC)45% rev
  • Metformin & Other APIs25% rev
  • Finished Dosage Forms (OTC Tablets)30% rev

Japanese pharmaceutical capsule company (HQ Kizugawa, Nara; Mitsubishi Chemical Group subsidiary); produces pharmaceutical-grade gelatin capsules and Quali-V HPMC (hydroxypropyl methylcellulose) vegetarian capsules. Qualicaps has manufacturing in Japan, Spain (Alcobendas), and the US (Whitsett NC), serving Japanese pharmaceutical majors (Daiichi-Sankyo, Takeda) and European/US pharmaceutical customers. Qualicaps HPMC (Quali-V) is a significant alternative to Lonza Capsugel's Vcaps for vegetarian capsule applications. Mitsubishi Chemical Group (the parent) is a major HPMC producer — the same Japanese chemical company that makes the HPMC polymer that goes into Qualicaps capsule shells also produces specialty resins, synthetic fibers, and advanced materials.

Supplies these inputs

Pharmaceutical capsule shells (gelatin / HPMC)

Replaceability

Substitutability 30% · 24 mo to replace

Business segments

  • Gelatin Capsule Shells55% rev
  • HPMC Vegetarian Capsules (Quali-V)38% rev
  • Specialty Capsule Solutions7% rev

Where it's made

Facilities

8 facilities producing inputs that feed otc medicines.

Anqiu Lu'an Pharmaceutical Plant — Anqiu, Shandong

CN

Anqiu Lu'an Pharmaceutical · Shandong · manufacturing

World's largest single-site APAP API plant; 40,000–50,000 t/year capacity; also produces para-aminophenol (PAP) upstream. FDA Drug Master File filed 2011.

BASF Bishop TX Ibuprofen Plant

US

BASF SE · Texas · manufacturing

BASF's primary North American ibuprofen API production; uses BHC Green Chemistry 4-step process (1992) reducing raw material waste by 60% vs. original Boots synthesis. Acquired from Hoechst Celanese 1995.

Farmson Pharmaceutical Plant — Vadodara, Gujarat

IN

Farmson Pharmaceutical · Gujarat · manufacturing

Claims to be world's largest integrated APAP production plant; ~52,000 t/yr capacity; backward-integrated into PAP production; USFDA and UK MHRA approved.

Granules India Gagillapur API Plant — Hyderabad

IN

Granules India · Telangana · manufacturing

Primary APAP and ibuprofen API manufacturing site; US FDA approved; expanded by 6,400 tonnes/yr Q3 2024.

IOL Chemicals Fatehabad Plant — Punjab

IN

IOL Chemicals and Pharmaceuticals · Punjab · manufacturing

World's largest single ibuprofen API manufacturing facility; 12,000 t/yr; backward-integrated into isobutylbenzene (IBB) precursor. US FDA, UK MHRA, EU GMP certified.

Lonza Capsugel — Colmar, France

FR

Lonza Group · Alsace · manufacturing

Primary hard-shell gelatin and HPMC capsule manufacturing for pharmaceutical industry (Capsugel brand acquired 2017 for $5.5B); world's largest capsule manufacturing site.

Mallinckrodt Pharmaceuticals APAP Plant — Raleigh NC

US

Mallinckrodt Pharmaceuticals · North Carolina · manufacturing

The only APAP API manufacturing facility in North America; operating since 1971; capacity undisclosed but significant in domestic supply. Survived two Chapter 11 bankruptcies; currently operational but financially stressed.

Shandong Xinhua Pharmaceutical — Zibo

CN

Shandong Xinhua Pharmaceutical · Shandong · manufacturing

Primary aspirin API manufacturing facility; 10,000+ t/yr capacity; has supplied branded pharma companies (Bayer, Pfizer, GSK, Sanofi, Novartis) for decades. Shanghai Stock Exchange listed.